Back to top

Image: Bigstock

Zoetis (ZTS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Read MoreHide Full Article

Zoetis (ZTS - Free Report) reported $2.26 billion in revenue for the quarter ended March 2026, representing a year-over-year increase of 1.9%. EPS of $1.53 for the same period compares to $1.48 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $2.3 billion, representing a surprise of -1.66%. The company delivered an EPS surprise of -5.09%, with the consensus EPS estimate being $1.61.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Zoetis performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
  • Geographic Revenues- U.S.: $1.09 billion versus $1.2 billion estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -7.9% change.
  • Geographic Revenues- International Revenue: $1.15 billion versus the four-analyst average estimate of $1.08 billion. The reported number represents a year-over-year change of +14%.
  • Geographic Revenues- International- Companion Animal: $654 million versus $609.45 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +14.1% change.
  • Geographic Revenues- U.S.- Livestock: $225 million versus the three-analyst average estimate of $221.92 million. The reported number represents a year-over-year change of +7.1%.
  • Geographic Revenues- International- Livestock: $495 million versus the three-analyst average estimate of $465.47 million. The reported number represents a year-over-year change of +13.8%.
  • Revenues- Contract Manufacturing & Human Health: $23 million versus the four-analyst average estimate of $28.94 million. The reported number represents a year-over-year change of -20.7%.
  • Revenues- Companion Animal: $1.52 billion versus $1.58 billion estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -1.8% change.
  • Revenues- Livestock: $720 million versus $680.48 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +11.6% change.
  • Revenues- Livestock- Swine: $123 million compared to the $112.11 million average estimate based on two analysts. The reported number represents a change of +10.8% year over year.
  • Revenues- Livestock- Cattle: $392 million versus the two-analyst average estimate of $370.52 million. The reported number represents a year-over-year change of +9.5%.
  • Revenues- Livestock- Fish: $66 million versus the two-analyst average estimate of $57 million. The reported number represents a year-over-year change of +24.5%.
  • Revenues- Livestock- Poultry: $118 million compared to the $110.22 million average estimate based on two analysts. The reported number represents a change of +11.3% year over year.

View all Key Company Metrics for Zoetis here>>>

Shares of Zoetis have returned -7.1% over the past month versus the Zacks S&P 500 composite's +11.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Zacks' 7 Best Strong Buy Stocks (New Research Report)

Valued at $99, click below to receive our just-released report predicting the 7 stocks that will soar highest in the coming month.

Click Here, It's Really Free

Published in